- Home
- ARWR vs QS Comparison
ARWR vs QS Comparison
Compare ARWR & QS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- QS
- Stock Information
- Founded
- ARWR 2003
- QS 2010
- Country
- ARWR United States
- QS United States
- Employees
- ARWR N/A
- QS N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- QS Auto Parts:O.E.M.
- Sector
- ARWR Health Care
- QS Consumer Discretionary
- Exchange
- ARWR Nasdaq
- QS Nasdaq
- Market Cap
- ARWR 1.7B
- QS 2.0B
- IPO Year
- ARWR 1993
- QS N/A
- Fundamental
- Price
- ARWR $13.25
- QS $3.95
- Analyst Decision
- ARWR Buy
- QS Sell
- Analyst Count
- ARWR 11
- QS 7
- Target Price
- ARWR $41.44
- QS $5.26
- AVG Volume (30 Days)
- ARWR 2.2M
- QS 9.8M
- Earning Date
- ARWR 05-08-2025
- QS 04-23-2025
- Dividend Yield
- ARWR N/A
- QS N/A
- EPS Growth
- ARWR N/A
- QS N/A
- EPS
- ARWR N/A
- QS N/A
- Revenue
- ARWR $2,500,000.00
- QS N/A
- Revenue This Year
- ARWR $4,380.43
- QS N/A
- Revenue Next Year
- ARWR $64.24
- QS N/A
- P/E Ratio
- ARWR N/A
- QS N/A
- Revenue Growth
- ARWR N/A
- QS N/A
- 52 Week Low
- ARWR $9.57
- QS $3.40
- 52 Week High
- ARWR $30.41
- QS $9.52
- Technical
- Relative Strength Index (RSI)
- ARWR 50.85
- QS 46.57
- Support Level
- ARWR $10.92
- QS $3.79
- Resistance Level
- ARWR $13.45
- QS $4.25
- Average True Range (ATR)
- ARWR 1.10
- QS 0.28
- MACD
- ARWR 0.41
- QS 0.05
- Stochastic Oscillator
- ARWR 94.85
- QS 64.71
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
About QS QuantumScape Corporation
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles and other applications. The company's solid-state lithium-metal battery technology is designed to offer greater energy density, faster charging, and enhanced safety. Its battery cells have none of the host materials used in conventional anodes.